Regulatory Consulting

Regulatory Consulting

Clinical Development in Japan,from Concept to Marketing Approval Application

Accerise, Inc. provides a broad range of support for products including pharmaceuticals, medical devices and regenerative medical products.
Our services cover assessments of Japan's market and development landscape, regulatory strategy, PMDA consultations, clinical trial notifications (CTNs) and marketing approval applications.

Contact Us
SCROLL
Regulatory submission documents and small pharmaceutical vials on a sunlit desk
OUR STRENGTHS

The Right Approach and Flexibilityfor Your Project

Accerise, Inc. responds quickly and flexibly to your project's needs and challenges.
From regulatory strategy and PMDA consultations to clinical trial notifications, CTD/STED preparation and responses to regulatory queries, we tailor the scope of support to your requirements.

Contact Us

SERVICES

We provide regulatory consulting tailored to each stage of your project, from assessing entry into the Japanese market and defining regulatory and development strategies to preparing marketing approval applications.

01

Development Strategy

We develop strategies for development and regulatory approval in Japan based on research into competing products under development.

02

Development & Study Planning

We help plan development programs and studies around Japan's medical needs and regulatory requirements, with future marketing approval applications in mind.

03

PMDA Consultation & Clinical Trial Notification

We support the preparation of briefing documents for PMDA consultations, responses to regulatory queries, clinical trial notification submissions, and jRCT registration to support the smooth initiation of clinical trials.

04

Marketing Approval Application Support

We assist with preparation and review of application dossiers, eCTD submissions, and clinical study data, including CDISC-compliant datasets, as well as responses to queries during PMDA review.

05

Orphan Drug Designation & Related Regulatory Support

We support applications for orphan designation and related regulatory programs for pharmaceuticals and medical devices.

SELECTED EXPERIENCE

01

Regulatory Strategy & Development Planning for Japan

02

Japanese Market & Development Landscape Assessment

03

PMDA Consultations:Briefing Document Preparation & Responses to Regulatory Queries

04

Clinical Trial Notification (CTN) Support

05

Orphan Drug Designation (ODD) Support

06

Marketing Approval Applications & CTD Preparation

HOW WE WORK

01

Initial Inquiry & Needs Assessment

We review your product information, development status and the support you are seeking.

02

Proposal & Quotation

We propose services and an approach tailored to your requirements, together with a quotation.

03

Agreement & Project Kickoff

After you approve our proposal and the agreement is signed, we begin work.

04

Work Completed

We review progress and deliverables to ensure that agreed project objectives are met.

CONTACT US

Talk to Us About Your Regulatory Needs

Whether you are exploring entry into the Japanese market, preparing for PMDA consultations, initiating clinical trials or planning a marketing approval application, we can discuss the support you need at your current stage.